Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d71eb3acb1c7694e4a32a4bf8524d184 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e52f832180398ef9faf6f80f61e7e2d6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_55d4b9c0c9213154650ba06ebe99ce8b |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2210-0675 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M31-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2210-0618 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2205-583 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2202-0488 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M11-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M15-009 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M15-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M15-085 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F11-00 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M31-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M11-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F11-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M15-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M15-00 |
filingDate |
2019-01-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2020-10-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7a685fd04cf47442f4d406507bbc0bee http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_908d193aab798afd1b3b08e105b0cc3a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_37df606fbc47d87efe3e58b186bd819f |
publicationDate |
2020-10-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-10814076-B2 |
titleOfInvention |
Method for enhancing eustachian tube patency and treatment of otitis media |
abstract |
A method of increasing eustachian tube patency in human patients is disclosed wherein a eustachian tube targeting nasal administration device is utilized to deliver a surfactant/propellant mixture to the nasopharyngeal stoma of the auditory tube. The targeting capability of the administration device obviates the need for a spreading agent that would otherwise be required to enable at least a portion of surfactant to reach the eustachian tube orifice. More specifically, the non-targeting, indiscriminate delivery provided by nasal administration devices of the past required surfactant to spread over non-targeted tissue it was inadvertently applied to in order to reach the eustachian tube stoma. In addition, a method for treatment of otitis media is disclosed utilizing, in some preferred embodiments, a therapeutically active agent. |
priorityDate |
2017-01-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |